Pharmacovigilance deep dive: risk minimisation measures
European Pharmaceutical Review
SEPTEMBER 2, 2022
RMMs aim to optimise the safe and effective use of medical products in clinical practice by improving their risk-benefit balance. She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. US Food and Drug Administration.
Let's personalize your content